Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Featured Article of the Month

  • MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
    Open Access
    MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
    Julie Constanzo, Aliasghar Parach, Timothee David, Joshua Karam, Frank Bruchertseifer, Alfred Morgenstern, Marta Jarlier, Manuel Bardiès, Emmanuel Deshayes, Amelie Gudin-de-Vallerin, Florence Boissière-Michot, Evelyne Lopez-Crapez and Jean-Pierre Pouget
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 785-792; DOI: https://doi.org/10.2967/jnumed.124.268857
  • IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
    You have access
    IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
    Leah Gajecki, Irina V. Lebedeva, Yu-Rou Liao, Daisy Ambriz, Lukas M. Carter, Melina Kumpf, Samantha Lovibond, Justin S. Hachey, Maya S. Graham, Michael Postow, Jason S. Lewis, David P. Andrew, Manuel Baca, Heiko Schöder, Steven M. Larson, Darren R. Veach and Simone Krebs
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 605-611; DOI: https://doi.org/10.2967/jnumed.124.268762
  • Pilot Study of Nectin-4–Targeted PET Imaging Agent <sup>68</sup>Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human
    You have access
    Pilot Study of Nectin-4–Targeted PET Imaging Agent 68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human
    Li Sun, Yuyun Sun, Ke Zuo, Lei Fan, Xiao Wang, Jianping Zhang, Silong Hu, Xiaosheng Liu, Jindian Li, Ye Li, Zhiming Shao, Xiaoping Xu, Aiguo Wu and Shaoli Song
    Journal of Nuclear Medicine March 1, 2025, 66 (3) 473-479; DOI: https://doi.org/10.2967/jnumed.124.269024
  • <sup>177</sup>Lu-DOTATATE Plus Capecitabine Versus <sup>177</sup>Lu-DOTATATE Alone in Patients with Advanced Grade 1/2 Gastroenteropancreatic Neuroendocrine Tumors (LuCAP): A Randomized, Phase 2 Trial
    You have access
    177Lu-DOTATATE Plus Capecitabine Versus 177Lu-DOTATATE Alone in Patients with Advanced Grade 1/2 Gastroenteropancreatic Neuroendocrine Tumors (LuCAP): A Randomized, Phase 2 Trial
    Swayamjeet Satapathy, Piyush Aggarwal, Ashwani Sood, Kunal R. Chandekar, Chandan K. Das, Rajesh Gupta, Divya Khosla, Namrata Das, Rakesh Kapoor, Rajender Kumar, Harmandeep Singh, Jaya Shukla, Ajay Kumar and Bhagwant Rai Mittal
    Journal of Nuclear Medicine February 1, 2025, 66 (2) 238-244; DOI: https://doi.org/10.2967/jnumed.124.268617
  • Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
    You have access
    Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
    Peng Hou, Haiming Chen, Sihao Liang, Wenliang Guo, Ruiyue Zhao, Huailu Pan, Haimin Liu, Youcai Li, Jie Lv, Kaixiang Zhong, Miao Ke, Yimin Fu, Huizhen Zhong, Xinlu Wang and Cheng Hong
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 98-103; DOI: https://doi.org/10.2967/jnumed.124.268376
  • Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
    Open Access
    Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
    Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O. Richard, Atefeh Zamanian, Stephan Probst, Éric Lévesque, Vincent Castonguay, Nicolas Marcoux, Michele Lodde, Daniel Juneau, Zineb Hamilou, Jean-Baptiste Lattouf, François-Alexandre Buteau, Michel Pavic, Jean-François Castilloux, Bertrand Neveu, Guillaume F. Bouvet, Catherine Allard, Amélie Tétu, Brigitte Guérin, Jean-Mathieu Beauregard and for the 3TMPO Investigators
    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1710-1717; DOI: https://doi.org/10.2967/jnumed.124.268020
  • [<sup>68</sup>Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series
    You have access
    [68Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series
    Alex J. Poot, Constantin Lapa, Wolfgang A. Weber, Marnix G.E.H. Lam, Matthias Eiber, Alexander Dierks, Ralph A. Bundschuh and Arthur J.A.T. Braat
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1597-1603; DOI: https://doi.org/10.2967/jnumed.124.268147
  • Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network
    You have access
    Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network
    Aurelien Fosse, Julien Hadoux, Paul Girot, Amandine Beron, Pauline Afchain, Anne-Segolene Cottereau, Eric Baudin, Lawrence O. Dierickx, Thierry Lecomte, Marine Perrier, Come Lepage, Karine Bouhier-Leporrier, Bernard Goichot, Boumediene Lachachi, Thomas Walter and Alice Durand
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1416-1422; DOI: https://doi.org/10.2967/jnumed.123.267363
  • Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager
    Open Access
    Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager
    Hongdi Li, Ramsey D. Badawi, Simon R. Cherry, Kathryn Fontaine, Liuchun He, Shannan Henry, Ansel T. Hillmer, Lingzhi Hu, Nikkita Khattar, Edwin K. Leung, Tiantian Li, Yusheng Li, Chi Liu, Peng Liu, Zhenrui Lu, Stanislaw Majewski, David Matuskey, Evan D. Morris, Tim Mulnix, Negar Omidvari, Suranjana Samanta, Aaron Selfridge, Xishan Sun, Takuya Toyonaga, Tommaso Volpi, Tianyi Zeng, Terry Jones, Jinyi Qi and Richard E. Carson
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1320-1326; DOI: https://doi.org/10.2967/jnumed.124.267767
  • Deescalated <sup>225</sup>Ac-PSMA-617 Versus <sup>177</sup>Lu/<sup>225</sup>Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients
    You have access
    Deescalated 225Ac-PSMA-617 Versus 177Lu/225Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients
    Hendrik Rathke, Erik Winter, Frank Bruchertseifer, Manuel Röhrich, Frederik Lars Giesel, Uwe Haberkorn, Alfred Morgenstern and Clemens Kratochwil
    Journal of Nuclear Medicine July 1, 2024, 65 (7) 1057-1063; DOI: https://doi.org/10.2967/jnumed.123.267206

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2025 SNMMI

Powered by HighWire